Citation Impact
Citing Papers
Meat Consumption, Nonsteroidal Anti-Inflammatory Drug Use, and Mortality among Colorectal Cancer Patients in the California Teachers Study
2010
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
1996
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Inflammation and cancer
2002 StandoutNature
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA
2000
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
The role of cyclooxygenases in inflammation, cancer, and development
1999
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Global Cancer Statistics, 2002
2005 Standout
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents
1998
Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis
1999
Distribution and function of prostanoid receptors: studies from knockout mice
2000
Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues
2002
Cyclooxygenase knockout mice
1999
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate
2000
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
1995
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
2007
Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes
2002
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
1998
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Chemoprevention of Colorectal Cancer
2000
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop
1994
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
1997
Lessons from Hereditary Colorectal Cancer
1996 Standout
Colorectal cancer
2013 Standout
Chemoprevention of Colon Cancer by Organoselenium Compounds and Impact of High- or Low-Fat Diets
1997
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
1994 Standout
Modifiable risk factors for colon cancer
2002
Piroxicam decreases postirradiation colonic neoplasia in the rat
1990
PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
2009
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
2000 StandoutNatureNobel
The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
1995
Sulindac Inhibits Activation of the NF-κB Pathway
1999
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers
1998
Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels
2001
Aspirin use, cancer, and polyps of the large bowel
1993
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
2001
Immunity, Inflammation, and Cancer
2010 Standout
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database
2000
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesis
2003
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
1996 Standout
Lactobacillus‐ and bifidobacterium‐mediated antigenotoxicity in the colon of rats
1996
Gut flora in health and disease
2003 Standout
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Chemoprevention of gastrointestinal cancer
1997
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Eicosanoids and the gastrointestinal tract
1995
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)
1998
Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions☆
1999
Tumorigenic Transformation of Immortalized ECV Endothelial Cells by Cyclooxygenase-1 Overexpression
1997
Cancer-related inflammation
2008 StandoutNature
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Development of novel therapeutic strategies that target HIF-1
2006 StandoutNobel
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
2009
COX-2 inhibitors
1999 Standout
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
1995 Standout
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
2001
Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
1993
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
1996 Standout
Aspirin use and risk of fatal cancer.
1993
Nonsteroidal Anti-Inflammatory Drugs and Cancer Prevention
2000
Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
1990
Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
1993
Aspirin Use and Reduced Risk of Fatal Colon Cancer
1991 Standout
p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo.
2001
Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.
2003 StandoutNobel
The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention.
2000
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
1991
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
1996
Risk of malignancy among patients with rheumatic conditions
2000
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
2000 StandoutNobel
Dioxygen Activation at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates
2004 Standout
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
1998
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
1997
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
2001
Prevention--therapy--basic science and the resolution of the cancer problem.
1993
Works of Gary Kelloff being referenced
Modulation of azoxymethane-induced mutational activation of ras protooncogenese by chemopreventive agents in colon carcinogenesis
1994
Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents
1994
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
1993
SHORT COMMUNICATION: Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats
1996
Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.
1987
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
1995